• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number RONYX25034UX
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Myocardial Infarction (1969); Occlusion (1984)
Event Date 01/13/2020
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
One 2.25x34mm resolute onyx drug eluting stent was successfully implanted in the mid lad ((b)(6) 2020) at different facility.Approx 3 days later ((b)(6) 2020) the patient presented with stemi, and the lad was 100% totally occluded from the distal lm.There was no flow in lad and circumflex and ramus vessels.The patient was taking dapt as prescribed.An attempt was made to treat the patient with two resolute onyx rx coronary drug-eluting stents (2.25x30mm resolute onyx, and 3.5 x 22mm resolute onyx).The lesion was a moderately tortuous, moderately calcified lesion located in the mid, proximal left main (lm) coronary artery/left anterior descending (lad) artery/ramus branch.Both devices were inspected with no issues noted.Negative prep was performed on both devices without issues.Both devices did not pass through previously deployed stents.The lad and circumflex vessels were wired and pre-dilated.Resistance was not encountered when advancing the 3.5 x 22mm resolute onyx device.Excessive force was not used during delivery.Resistance was encountered when advancing the 2.25x30mm resolute onyx.A resolute onyx stent was placed in the proximal circumflex.The 3.5 x 22mm resolute onyx stent was placed in the distal lm to mid lad overlapping the 2.25 x 34mm resolute onyx stent that was previously implanted 3 days earlier.There was no issue during deployment of the 3.5 x 22mm resolute onyx stent and it was fully expanded.The ramus was wired and the 2.25x30mm resolute onyx was advanced through to the ramus branch.It was reported that the 2.25x30mm resolute onyx stent failed to cross the lesion and upon attempting to remove the undeployed stent, significant resistance was felt.It was noted on removal of the balloon that the 2.25x30mm resolute onyx stent had dislodged in the proximal lad.The 2.25x30mm resolute onyx stent was successfully retrieved using a goose neck snare.However, upon pulling back the 2.25x30mm resolute onyx stent with the snare, it got caught and pulled out the 3.5 x 22mm resolute onyx stent that had just been deployed in the lad, with both stents coming back into the guide.Another 3.5 x 22 onyx was implanted successfully in the proximal lad.Patient is currently in the icu without a balloon pump.
 
Manufacturer Narrative
Additional information: the stent implanted in the mid lad at the first hospital was a resolute onyx 2.5 x 34mm and it was deployed at 17 atm for 20 secs.The lesion had been pre-dilated with 1.5mm, 2.0mm and 2.5mm euphora balloon catheters.Three days later at the second hospital, an export aspiration catheter was used.2.0mm, 2.5mm and 3.0mm sc euphora balloon catheters were used.A 2.5x15mm resolute onyx drug eluting stent was deployed at 16 atm in the lcx.The 3.5 x 22mm resolute onyx stent was fully expanded at 18 atm.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Image analysis summary: images were provided for review.Intravascular ultrasound images of the left main, left coronary artery and ramus branch were reviewed.From the images provided the moderate calcified anatomy of the vessel can be confirmed.Severe luminal narrowing with the intimal ¿ medial wall thickening with circular plaque of predominantly fibrous-lipid tissue was observed.Correction: device catalog number.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9646405
MDR Text Key177380327
Report Number9612164-2020-00484
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 04/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/30/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberRONYX25034UX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/22/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age81 YR
-
-